2022 is a year of action for PSA

Ahead of a federal election and an energised remuneration campaign, PSA‘s Communities of Specialty Interest are preparing to power pharmacy practice in 2022 and beyond. 

Motion sickness

Though typically short-lived, motion sickness can be distressing and disruptive.

Urinary incontinence: let’s talk about leaks

Incontinence often leads to reduced quality of life and is under-recognised due to stigma.

Choosing Wisely – a look at prescribing cascades

In the first of a six-part series, we expand on the PSA Choosing Wisely recommendations. This month: beware the prescribing cascade. The decision to initiate...

Is combined NRT therapy the best bet for smoking cessation?

Groundbreaking new research has found that current smokers are three times more likely to die from cardiovascular disease (CVD), but these risks greatly decrease...

Chronic kidney disease: when the filters fail

Chronic kidney disease is a progressive long-term condition characterised by a gradual and usually irreversible decline in kidney function.